Hyperfine (HYPR) Current Assets (2020 - 2026)
Hyperfine (HYPR) posted Current Assets of $56.0 million for Q1 2026, up 10.07% on a QoQ basis from $50.9 million in Q4 2025, and up 15.76% year-over-year from $48.4 million in Q1 2025.
Hyperfine (HYPR) Current Assets (2020 - 2026) Analysis & Trends
Hyperfine's Current Assets history runs 7 years deep, the most recent figure standing at $56.0 million for Q1 2026.
- Quarterly Current Assets rose 15.76% year-over-year to $56.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56.0 million (up 15.76% YoY) and the FY2025 annual result came in at $50.9 million, down 5.22% from the prior year.
- Current Assets was $56.0 million for Q1 2026 at Hyperfine, up from $50.9 million in the prior quarter.
- Across five years, Current Assets topped out at $173.7 million in Q1 2022 and bottomed at $36.9 million in Q3 2025.
- A 5-year average of $89.2 million and a median of $79.7 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets jumped 15393.33% — and 2025, when it slumped 43.55%.
- Hyperfine's Current Assets stood at $128.7 million in 2022, then plunged by 30.9% to $88.9 million in 2023, then slumped by 39.59% to $53.7 million in 2024, then slipped by 5.22% to $50.9 million in 2025, then climbed by 10.07% to $56.0 million in 2026.
- Business Quant data shows HYPR's Current Assets at $56.0 million in Q1 2026, $50.9 million in Q4 2025, and $36.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 4.33 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 11.45 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.43 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 4.10 Bn |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn | 56.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.03 Mn |
| Dec 31, 2025 | 50.91 Mn |
| Sep 30, 2025 | 36.90 Mn |
| Jun 30, 2025 | 40.10 Mn |
| Mar 31, 2025 | 48.40 Mn |
| Dec 31, 2024 | 53.71 Mn |
| Sep 30, 2024 | 64.09 Mn |
| Jun 30, 2024 | 71.03 Mn |
| Mar 31, 2024 | 79.69 Mn |
| Dec 31, 2023 | 88.91 Mn |
| Sep 30, 2023 | 98.22 Mn |
| Jun 30, 2023 | 107.82 Mn |
| Mar 31, 2023 | 117.14 Mn |
| Dec 31, 2022 | 128.66 Mn |
| Sep 30, 2022 | 143.72 Mn |
| Jun 30, 2022 | 157.03 Mn |
| Mar 31, 2022 | 173.73 Mn |
| Dec 31, 2021 | 197.49 Mn |
| Sep 30, 2021 | 927,599.00 |
| Jun 30, 2021 | 1.24 Mn |